Publication | Closed Access

Study of COX-2, Ki67, and p53 expression to predict effectiveness of 5-flurouracil, epirubicin and cyclophosphamide with celecoxib treatment in breast cancer patients

OncologyCelecoxib TreatmentBreast Cancer PatientsMedicineP53 ExpressionPathologyBreast CancerAnti-cancer AgentCancer TreatmentPharmacologyTumor MicroenvironmentCancer Research